Document Details
Form
Filing Date
May 15, 2024
Document Date
May 13, 2024
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
BioCryst Pharmaceuticals, Inc.
Issuer
BIOCRYST PHARMACEUTICALS INC
Filer
Galson Steven K